help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2009-0543
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Böni-Schnetzler, M.
Right arrow Articles by Donath, M. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Böni-Schnetzler, M.
Right arrow Articles by Donath, M. Y.
Endocrinology Vol. 150, No. 12 5218-5229
Copyright © 2009 by The Endocrine Society

Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I

Marianne Böni-Schnetzler, Simone Boller, Sarah Debray, Karim Bouzakri, Daniel T. Meier, Richard Prazak, Julie Kerr-Conte, Francois Pattou, Jan A. Ehses, Frans C. Schuit and Marc Y. Donath

Division of Endocrinology, Diabetes, and Nutrition (M.B.-S., S.B., D.T.M., R.P., J.A.E., M.Y.D.) and Center for Integrated Human Physiology, University Hospital Zurich, CH-8091 Zurich, Switzerland; Gene Expression Unit (S.D., F.C.S.), Department of Molecular Cell Biology, Katholieke Universiteit Leuven, 3000 Leuven, Belgium; Department of Genetic Medicine and Development (K.B.), University of Geneva, 1211 Geneva 4, Switzerland; and Université Lille Nord de France (J.K.-C., F.P.), Université de Droits et de Santé de Lille, Centre Hospitalier Universitaire Lille, Institut National de la Santé et de la Recherche Médicale Unité 859, Biotherapies for Diabetes, F-59000 Lille, France

Address all correspondence and requests for reprints to: Marianne Böni-Schnetzler, Ph.D., Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University Hospital, CH-8091 Zurich, Switzerland. E-mail: marianne. boeni{at}usz.ch.

Islets of patients with type 2 diabetes mellitus (T2DM) display features of an inflammatory process including elevated levels of the cytokine IL-1β, various chemokines, and macrophages. IL-1β is a master regulator of inflammation, and IL-1 receptor type I (IL-1RI) blockage improves glycemia and insulin secretion in humans with T2DM and in high-fat-fed mice pointing to a pivotal role of IL-1RI activity in intra-islet inflammation. Given the association of dyslipidemia and T2DM, we tested whether free fatty acids (FFA) promote the expression of proinflammatory factors in human and mouse islets and investigated a role for the IL-1RI in this response. A comparison of 22 mouse tissues revealed the highest IL-1RI expression levels in islets and MIN6 β-cells. FFA induced IL-1β, IL-6, and IL-8 in human islets and IL-1β and KC in mouse islets. Elevated glucose concentrations enhanced FFA-induced proinflammatory factors in human islets. Blocking the IL-1RI with the IL-1R antagonist (IL-1Ra) strongly inhibited FFA-mediated expression of proinflammatory factors in human and mouse islets. Antibody inhibition of IL-1β revealed that FFA stimulated IL-1RI activity via the induction of the receptor ligand. FFA-induced IL-1β and KC expression in mouse islets was completely dependent on the IL-1R/Toll-like receptor (TLR) docking protein Myd88 and partly dependent on TLR2 and -4. Activation of TLR2 in purified human β-cells and islets stimulated the expression of proinflammatory factors, and IL-1RI activity increased the TLR2 response in human islets. We conclude that FFA and TLR stimulation induce proinflammatory factors in islets and that IL-1RI engagement results in signal amplification.




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. M. Owyang, K. Maedler, L. Gross, J. Yin, L. Esposito, L. Shu, J. Jadhav, E. Domsgen, J. Bergemann, S. Lee, et al.
XOMA 052, an Anti-IL-1{beta} Monoclonal Antibody, Improves Glucose Control and {beta}-Cell Function in the Diet-Induced Obesity Mouse Model
Endocrinology, June 1, 2010; 151(6): 2515 - 2527.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
K. Schroder, R. Zhou, and J. Tschopp
The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Science, January 15, 2010; 327(5963): 296 - 300.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society